Trial intelligence / Profile preview

Tragacanth herbal cream versus mometasone for mild to moderate hand eczema

IRCT20190914044767N1Phase 3Completed

Sponsor
Traditional Medicine & Materia Medica Research Center
Start
Dec 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of tragacanth and mometasone in hand dermatitis (2 arms), sponsored by Traditional Medicine & Materia Medica Research Center. Primary endpoints: Symptoms of eczema and Participant consequences. Started Dec 2019; status: completed.

02

Drugs

tragacanthmometasone
03

Conditions

hand dermatitis

Beyond the preview

Go deeper on IRCT20190914044767N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190914044767N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call